Glycogen synthase kinase-3 modulates neurite outgrowth in cultured neurons: Possible implications for neurite pathology in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 1, Issue 6, 1999, Pages 361-378

  Munoz Montano, J R ^a   Lim, F ^a   Moreno, F J ^a   Avila, J ^a   Diaz Nido, J ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN; GLYCOGEN SYNTHASE KINASE 3; LITHIUM; TAU PROTEIN; VIRUS VECTOR;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL METABOLISM; CYTOSKELETON; GENE OVEREXPRESSION; GRANULE CELL; NERVE CELL; NERVE FIBER GROWTH; NEUROFIBRILLARY TANGLE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

EID: 0033296604     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-1999-1602     Document Type: Article

References (90)

1. Lithium protects cultured neurons against β-amyloid-induced neurodegeneration
2. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules
3. Inositol monophosphatase, the putative therapeutic target for lithium
4. Regulation of microtubule dynamics by microtubule-associated protein expression and phosphorylation during neuronal development
5. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease
6. Cadherins, catenins and APC protein: Interplay between cytoskeletal complexes and signaling pathways
7. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding
8. Serum-free B27/Neurobasal medium supports differential growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrus
9. Distribution of the phosphorylated microtubule-associated protein tau in developing cortical neurons
10. Developmental changes in tau phosphorylation: Fetal tau is transiently phosphorylated in a manner similar to paired helical filament-tau characteristic of Alzheimer's disease
11. Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3β transgenes
12. β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding
13. Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons
14. Suppression of MAP2 in cultured cerebellar macroneurons inhibits minor neurite formation
15. Dynamic microtubule ends are required for growth cone turning to avoid an inhibitory guidance cue
16. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
17. The role of microtubules in the growth and stabilisation of nerve fibres
18. Phosphorylation of a neuronal-specific beta-tubulin isotype
19. Disruption by lithium of phosphoinositide signaling in cerebellar granule cells in primary culture
20. Role of glycogen synthase kinase 3β as a negative regulator of dorsoventral axis formation in Xenopus embryos
21. Expression and characterization of glycogen synthase kinase-3 mutants and their effect on glycogen synthase activity in intact cells
22. Insulin-like growth factors regulate neuronal differentiation and survival
23. Implication of cyclin-dependent kinases and glycogen synthase kinase-3 in the phosphorylation of microtubule-associated protein 1B (MAP1B) in developing neuronal cells
24. Lithium induces morphological differentiation of mouse neuroblastoma cells
25. A defective HSV-1 vector expresses Escherichia coli β-galactosidase in cultured peripheral neurons
26. Long-term increases in neurotransmitter release from neuronal cells expressing a constitutively active adenylate cyclase from a herpes simplex virus type 1 vector
27. Molecular analysis of neuronal physiology by gene transfer into neurons with herpes simplex virus vectors
28. Isolation of phosphorylated peptides and proteins on ion exchange
29. The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development
30. Phosphatase activity toward abnormally phosphorylated tau decrease in Alzheimer disease brain
31. A phosphorylated epitope on MAP1B that is transiently expressed in growing axons in the developing rat nervous system
32. Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau
33. Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology
34. Immunochemical evidence that fragments of phosphorylated MAP5 (MAP1B) are bound to neurofibrillary tangles in Alzheimer's disease
35. Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos
36. Activation of the Wnt signaling pathway: A molecular mechanism for lithium action
37. Cytoplasmic mechanisms of axonal and dendritic growth in neurons
38. Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons
39. Lithium chloride alters cytoskeletal organization in growing, but not mature, cultured chick sensory neurons
40. A novel tubulin-dependent protein kinase forming a paired helical filament epitope on tau
41. Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filaments
42. Tau protein kinase I converts normal tau protein into A68-like component of paired helical filaments
43. Nerve and epidermal growth factor induce protein synthesis and e1F2B activation in PC12 cells
44. A molecular mechanism for the effect of lithium on development
45. Inhibition of neurite initiation and growth by taxol
46. Autoradiographic localization and depolarization-induced release of acidic amino acids in differentiating cerebellar granule cell cultures
47. Preparation of 98% pure cerebellar granule cell cultures
48. Human rhinovirus 3C protease: Cloning and expression of an active form in Escherichia coli
49. Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells
50. Progressive and spatially differentiated stability of microtubules in developing neuronal cells
51. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells
52. The phosphorylation of tau: A critical stage in neurodevelopment and neurodegenerative processes
53. Phosphorylation of tau by glycogen synthase kinase-3β in intact mammalian cells: The effects on the organization and stability of microtubules
54. Inhibition of GSK-3β leading to the loss of phosphorylated MAP1B is an early event in axonal remodelling induced by WNT-7a or lithium
55. WNT-7a induces axonal remodelling and increased synapsin I level in cerebellar neurons
56. PKB/Akt: Connecting phosphoinositide 3-kinase to cell survival beyond
57. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau
58. Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons
59. Down-regulation of glycogen synthase kinase-3β (GSK-3β) protein expression during neuroblastoma IMR-32 cell differentiation
60. Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51
61. Phosphorylation determines two distinct species of tau in the central nervous system
62. Microtubules containing acetylated α-tubulin in mammalian cells in culture
63. Glycogen synthase kinase-3: Functions in oncogenesis and development
64. Filament heterogeneity within the dystrophic neurites of senile plaques suggests blockage of fast axonal transport in Alzheimer's disease
65. Insulin and related growth factors: Effects on the nervous system and mechanism for neurite growth and regeneration
66. Phosphorylated MAP1B, alias MAP5 and MAP1X, is involved in axonal growth and neuronal mitosis
67. Microtubule stability decreases axon elongation but not axoplasm production
68. Drosophila shaggy kinase and rat glycogen synthase kinase-3 have conserved activities and act downstream of Notch
69. Immunocytochemistry of tau phosphoserine 413 and tau protein kinase I in Alzheimer pathology
70. What are the facts and artifacts of the pathology and etiology of Alzheimer's disease?
71. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter
72. Tau protein pathology in neurodegenerative diseases
73. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
74. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
75. Involvement of tau protein kinase I in paired helical filament-like phosphorylation of the juvenile tau in rat brain
76. Localization and developmental changes of tau protein kinase I/glycogen synthase kinase-3β in rat brain
77. Exposure of rat hippocampal neurons to amyloid-β peptide induces the inactivation of phosphatidyl inositol 3-kinase and the activation of tau protein kinase I/glycogen synthase kinase-3β
78. Tau protein kinase I is essential for amyloid-β protein-induced neurotoxicity
79. Activation of tau protein kinase I/glycogen synthase kinase-3β by amyloid-β peptide enhances phosphorylation of tau in hippocampal neurons
80. The role of microtubule dynamics in growth cone motility and axonal growth
81. Heterogeneity in the phosphorylation of microtubule-associated protein MAP1B during rat brain development
82. Localization of differentially phosphorylated isoforms of microtubule-associated protein 1B in cultured rat hippocampal neurons
83. Microtubule-associated protein MAP1B showing a fetal phosphorylation pattern is present in sites of neurofibrillary degeneration in brain of Alzheimer's disease patients
84. Cellular phosphorylation of tau by GSK-3β influences tau binding to microtubules and microtubule organisation
85. Peptide substrates suitable for assaying glycogen synthase kinase-3 in crude cell extracts
86. GSK3: A shaggy frog story
87. Molecular cloning and expression of glycogen synthase kinase-3/factor A
88. Axon growth: Roles of microfilaments and microtubules
89. Mechanisms of neuronal degeneration in Alzheimer's disease
90. Dynamics of axonal microtubules regulate the topology of new membrane insertion into the growing neurites